Clinical Trial Update: Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing exemestane to anastrozole as first-line hormone therapy in postmenopausal metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Exemestane (Exemestane)

Snippet

Sponsor: Spanish Breast Cancer Research Group | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED